MK0767 in Type 2 Diabetes (0767-012)

NCT00543556 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

514

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: MK0767

Sponsor

Merck Sharp & Dohme LLC